Abstract | INTRODUCTION: METHODS: In six integrated health systems, we examined HZ incidence among children turning 12 months old during 2003-2008. All received varicella and MMR vaccines on recommended schedules. Cases were identified through 2014 using ICD-9 codes. Incidence was examined by number of varicella vaccine doses and same-day MMR. RESULTS: Among 199,797 children, overall HZ incidence was 18.6/100,000 person-years in the first-dose MMR + VAR group, 17.9/100,000 person-years in the MMRV group, and 7.5/100,000 person-years in the VAR-alone group. HZ incidence was lower following the second dose than before the second dose in all first-dose groups. CONCLUSIONS: HZ incidence was not meaningfully different between the MMRV and MMR + VAR first-dose groups. Overall and within first-dose groups, HZ incidence was lower among children receiving two varicella vaccine doses.
|
Authors | Sheila Weinmann, Stephanie A Irving, Padma Koppolu, Allison L Naleway, Edward A Belongia, Simon J Hambidge, Michael L Jackson, Nicola P Klein, Bruno Lewin, Elizabeth Liles, Mona Marin, Ning Smith, Eric Weintraub, Colleen Chun |
Journal | Vaccine
(Vaccine)
Vol. 38
Issue 37
Pg. 5880-5884
(08 18 2020)
ISSN: 1873-2518 [Electronic] Netherlands |
PMID | 32444193
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Copyright | Copyright © 2020 Elsevier Ltd. All rights reserved. |
Chemical References |
- Antibodies, Viral
- Chickenpox Vaccine
- Measles-Mumps-Rubella Vaccine
- Vaccines, Combined
|
Topics |
- Antibodies, Viral
- Chickenpox
(epidemiology, prevention & control)
- Chickenpox Vaccine
- Herpes Zoster
(epidemiology, prevention & control)
- Humans
- Incidence
- Infant
- Measles
- Measles-Mumps-Rubella Vaccine
- Mumps
(epidemiology, prevention & control)
- Vaccines, Combined
|